Arkolith/Insider Trading/BLTE/Form 4

Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Apr 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$163K
Net Open-Market Flow
-$163K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2026Sell(S)44$160.83$7K9K
Apr 27, 2026Sell(S)280$161.62$45K8K
Apr 27, 2026Sell(S)231$162.38$38K8K
Apr 27, 2026Sell(S)409$163.56$67K8K
Apr 27, 2026Sell(S)36$164.07$6K8K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-187224) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML